Publication | Closed Access

Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties

Psychoactive DrugPsychiatryMedicinePsychotropic MedicationBehavioural PharmacologyNeuropharmacologyPharmacotherapyPartial AgonistsPharmacologyHuman MetaboliteDrug Discovery